Antihypertensive and Renal Mechanisms of SGLT2 (Sodium-Glucose Linked Transporter 2) Inhibitors.

Wilcox, Christopher S

Wilcox, Christopher S.

Affiliation

Wilcox CS; From the Hypertension Center and Division of Nephrology and Hypertension, Georgetown University, Washington, DC.

Hypertension ; 75(4): 894-901, 2020 04.

Article in En | MEDLINE | ID: mdl-32114848

Subject(s)

Blood Pressure/drug effects; Hypertension/drug therapy; Hypoglycemic Agents/therapeutic use; Kidney/drug effects; Sodium-Glucose Transporter 2 Inhibitors/therapeutic use; Sodium-Hydrogen Exchangers/antagonists & inhibitors; Benzhydryl Compounds/pharmacology; Benzhydryl Compounds/therapeutic use; Blood Glucose; Canagliflozin/pharmacology; Canagliflozin/therapeutic use; Glucosides/pharmacology; Glucosides/therapeutic use; Humans; Hypertension/metabolism; Hypoglycemic Agents/pharmacology; Kidney/metabolism; Sodium-Glucose Transporter 2 Inhibitors/pharmacology; Sodium-Hydrogen Exchangers/metabolism

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Pressure / Sodium-Hydrogen Exchangers / Sodium-Glucose Transporter 2 Inhibitors / Hypertension / Hypoglycemic Agents / Kidney Limits: Humans Language: En Journal: Hypertension Year: 2020 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google